Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

ented PFS data, further define satraplatin's clinical profile as a potential second-line treatment option in metastatic HRPC.

In accordance with the recommendation of the independent Data Monitoring Board for the SPARC trial, patients who have not progressed continue to be treated and all patients will be followed for overall survival. Overall survival data are expected to be available later this year. Pharmion expects to complete the Marketing Authorization Application (MAA) for satraplatin for Europe in the second quarter of 2007. GPC Biotech recently completed the New Drug Application (NDA) submission for satraplatin to the U.S. Food and Drug Administration (FDA).

Safety findings were consistent with previous clinical studies involving satraplatin. The most common adverse reactions consisted of myelosuppression (bone marrow functions): Twenty-one percent of patients in the satraplatin arm experienced grade 3 or 4 thrombocytopenia; 14 percent had leucopenia and 21 percent had neutropenia. Eight percent of patients in the satraplatin arm experienced grade 3 or 4 gastrointestinal toxicities, including nausea (1.3%), vomiting (1.6%), diarrhea (2.1%) and constipation (2.1%). Five percent or less of patients in the satraplatin arm experienced grade 3 or 4 fatigue, grade 3 or 4 infections and pulmonary/respiratory grade 3 or 4 toxicities.

About Prostate Cancer

Prostate cancer is the most common cancer among men in the U.S. and Europe. Approximately 219,000 men in the U.S. are expected to be diagnosed with the disease in 2007 and over 27,000 men are expected to die from the disease. In the European Union, over 200,000 new cases are expected to be diagnosed, and over 60,000 patients are expected to die each year. Since the incidence of prostate cancer increases with age, the aging of the overall population is expected to further increase the number of prostate cancer patients.

Most patients diagnosed with prostate cancer initially receiv
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:7/10/2014)... CAESAREA, Israel , July 10, 2014 /PRNewswire/ ... Dario™ Diabetes Management Solution, today announced the appointment ... an independent member of its Board of Directors. ... of legal and business experience to LabStyle as ... director, and legal and corporate governance expert. He ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Solutions, Inc. (OTCQB: VHSLD) announced that it will begin ... Financial Industry Regulatory Authority has approved a change in ... ticker change has gone into effect for the trading ... the "D" will be removed from the ticker symbol ...
... Henry Schein, Inc., (NASDAQ: HSIC ), the ... practitioners, announced today that Stanley M. Bergman, Chairman ... the Company,s Executive Vice President and Chief Financial Officer, will ... on May 4, 2011. The conference is being held at ...
Cached Medicine Technology:Vertical Health Solutions to Begin Doing Business as OnPoint Medical Diagnostics and Announces Completion of Symbol Change 2Henry Schein to Present at Deutsche Bank 36th Annual Health Care Conference 2
(Date:7/10/2014)... (PRWEB) July 10, 2014 A ... program that gets clients off to a great start ... can believe in, has launched a new Eating Disorders ... The new section highlights:, , Different ... Statistic Manual of Mental Disorders (DSM-IV), including anorexia nervosa, ...
(Date:7/10/2014)... not nurture, may play the bigger role in the ... "As is the case in humans, genes matter ... William Hopkins of the Yerkes National Primate Research Center ... journal Current Biology . The findings might ... humans, Hopkins, team said. According to the researchers, ...
(Date:7/10/2014)... -- Men who have a vasectomy may be at ... suggests. But the risk is comparatively small, the ... study said more research is needed to determine if ... study, Harvard researchers analyzed data from more than 49,400 ... in 1986. During that time, 6,023 cases of prostate ...
(Date:7/10/2014)... 200 experts on aggression, who research issues ranging from ... 21st World Meeting of the International Society for Research ... 15-19. , Georgia State University is hosting the prestigious ... alternating continents. , "We are excited to be bringing ... which will help produce fresh ideas about the causes, ...
(Date:7/10/2014)... The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. , Titled ... model developed at UH to enhance care for adult ... need for high health care utilization. , ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... to smoke, researchers say , WEDNESDAY, Sept. 9 (HealthDay News) ... cigarettes, "tricks" the brain into creating memory associations between environmental ... smokers miss lighting up when they are in a bar ... at Baylor College of Medicine are in the Sept. 10 ...
... , , NEW YORK, ... zooming by, it might just be one of the Vespa LX 50 ... are adding to their autumn Breast Cancer Awareness initiatives. Through a partnership ... Breast Cancer for Life: The Power of 15," Vespa USA ( ...
... , , , PRINCETON, ... from around the globe will converge at Las Vegas, Mandalay ... Conference & Expo. , , Produced ... will focus on "Thinking Forward - The Power of the ...
... , , , ... awarded $7,500 in grants to 15 nonprofit organizations in Pennsylvania and ... grants were awarded through Highmark,s Employee Volunteer Grant Program, which reinforces ... to help local organizations carry out their missions in the community. ...
... , , WASHINGTON, Sept. 9 ... joining Pioneering Healthier Communities (PHC), its signature initiative that brings together ... through environmental and policy change. PHC is funded through a ... , , Since its inception in ...
... VILLAGE, Nev., Sept. 9 PDL BioPharma, Inc. (PDL) (Nasdaq: ... president and chief executive officer, will present at the BioCentury NewsMakers ... September 16, 2009 at 11:00 a.m. Eastern Time. , , ... the conference call, go to the company,s website at ...
Cached Medicine News:Health News:Nicotine Plays Tricks on Brain: Study 2Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 2Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 3Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 4Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 5Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 3Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 2Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 3Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 4Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 2Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 3Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 4Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 5
Bone Curette, 160 mm...
Bone Currettes...
London Endocervical Curette is a stainless-steel curette for obtaining endocervical samples with minimal effort....
...
Medicine Products: